Zobrazeno 1 - 7
of 7
pro vyhledávání: '"L Yu Kotlovskaya"'
Publikováno v:
Bulletin of Experimental Biology and Medicine. 173:419-423
Publikováno v:
Bulletin of experimental biology and medicine. 173(6)
We analyzed the content and functional activity of various types of regenerative-competent cells of the subventricular zone of the cerebral hemispheres in experimental mice under conditions of in vitro modeling of β-amyloid-induced neurodegeneration
Publikováno v:
Bulletin of experimental biology and medicine. 173(4)
We studied the role of JAKs and STAT3 in the growth potential of neural stem cells and the humoral neurotrophic function of neuroglia in modeling β-amyloid-induced neurodegeneration in vitro. It was found that these signaling molecules do not partic
Publikováno v:
Bulletin of experimental biology and medicine. 173(4)
The role of ERK1/2 and p38 in the realization of the growth potential of neural stem cells and secretion of neurotrophic growth factors by glial cells was studied using in vitro model of β-amyloid-induced neurodegeneration. It was shown that amyloid
Autor:
Yu.O. Samoylova, A.M. Dygay, L Yu Kotlovskaya, A.V. Panimaskina, M. Yu. Kotlovskiy, S.V. Gusakova, I.V. Dolgalev, V.V. Ivanov, V.N. Vasil'ev, I. Yu. Yakimovich
Publikováno v:
Ulyanovsk Medico-biological Journal. :106-113
The objective of the paper is to study the effects of anaerobic exercise on fatty acids percentage in adipose tissues of different localization under high-calorie diets in rats. Materials and Methods. The authors examined Wistar rats under high calor
Publikováno v:
Bulletin of experimental biology and medicine. 170(5)
A single intraperitoneal administration of cisplatin in the MTD to outbred female mice disturbed hemostasis and formed the procoagulant phenotype of hemostatic potential on days 7-10 culminating in a pronounced hypocoagulation on day 15. Hemostasis w
Publikováno v:
Bulletin of experimental biology and medicine. 170(1)
Procoagulant status was modeled in outbred female mice by single injection of cisplatin in a maximum tolerated dose and hemostasis parameters monitored over 30 days by methods of coagulogram and low-frequency piezothromboelastography (global test). M